EAM Global Investors’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-63,279
| Closed | -$1.71M | – | 245 |
|
2022
Q3 | $1.71M | Buy |
+63,279
| New | +$1.71M | 0.45% | 103 |
|
2020
Q3 | – | Sell |
-40,541
| Closed | -$990K | – | 179 |
|
2020
Q2 | $990K | Sell |
40,541
-69,398
| -63% | -$1.69M | 0.45% | 108 |
|
2020
Q1 | $1.63M | Sell |
109,939
-26,504
| -19% | -$392K | 0.95% | 42 |
|
2019
Q4 | $2.21M | Buy |
+136,443
| New | +$2.21M | 0.89% | 37 |
|
2018
Q2 | – | Sell |
-44,898
| Closed | -$1.38M | – | 189 |
|
2018
Q1 | $1.38M | Hold |
44,898
| – | – | 0.72% | 36 |
|
2017
Q4 | $1.61M | Buy |
+44,898
| New | +$1.61M | 0.82% | 10 |
|